ID: ALA2017022

Max Phase: Preclinical

Molecular Formula: C16H26N6O6S

Molecular Weight: 430.49

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)CC(C)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C16H26N6O6S/c1-8(2)4-9(3)21-14-11-15(19-6-18-14)22(7-20-11)16-13(24)12(23)10(28-16)5-27-29(17,25)26/h6-10,12-13,16,23-24H,4-5H2,1-3H3,(H2,17,25,26)(H,18,19,21)/t9?,10-,12-,13-,16-/m1/s1

Standard InChI Key:  NPHCCRFVTHZKNR-CALCHNCGSA-N

Associated Targets(Human)

SUMO-activating enzyme 861 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Ubiquitin-like modifier-activating enzyme 5 22 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 430.49Molecular Weight (Monoisotopic): 430.1635AlogP: -0.49#Rotatable Bonds: 8
Polar Surface Area: 174.71Molecular Species: NEUTRALHBA: 11HBD: 4
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.30CX Basic pKa: 3.73CX LogP: -0.28CX LogD: -0.28
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.43Np Likeness Score: 0.40

References

1. Lukkarila JL, da Silva SR, Ali M, Shahani VM, Xu GW, Berman J, Roughton A, Dhe-Paganon S, Schimmer AD, Gunning PT..  (2011)  Identification of NAE Inhibitors Exhibiting Potent Activity in Leukemia Cells: Exploring the Structural Determinants of NAE Specificity.,  (8): [PMID:24900352] [10.1021/ml2000615]

Source